Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 26 04:00PM ET
39.86
Dollar change
+0.79
Percentage change
2.02
%
Index- P/E14.49 EPS (ttm)2.75 Insider Own0.00% Shs Outstand2.04B Perf Week1.30%
Market Cap81.28B Forward P/E8.85 EPS next Y4.50 Insider Trans- Shs Float2.04B Perf Month2.55%
Income5.65B PEG3.02 EPS next Q0.98 Inst Own15.41% Short Float0.68% Perf Quarter-2.57%
Sales38.62B P/S2.10 EPS this Y1.67% Inst Trans0.60% Short Ratio3.84 Perf Half Y2.63%
Book/sh8.57 P/B4.65 EPS next Y12.16% ROA7.72% Short Interest13.84M Perf Year11.12%
Cash/sh2.54 P/C15.71 EPS next 5Y4.80% ROE35.18% 52W Range33.67 - 45.92 Perf YTD7.56%
Dividend Est.1.55 (3.88%) P/FCF11.18 EPS past 5Y4.23% ROI15.41% 52W High-13.21% Beta0.65
Dividend TTM1.49 (3.74%) Quick Ratio0.58 Sales past 5Y-1.06% Gross Margin70.84% 52W Low18.37% ATR (14)0.60
Dividend Ex-DateMay 16, 2024 Current Ratio0.87 EPS Y/Y TTM-66.49% Oper. Margin23.51% RSI (14)52.56 Volatility1.17% 1.27%
Employees70212 Debt/Eq1.28 Sales Y/Y TTM10.37% Profit Margin14.62% Recom2.42 Target Price48.43
Option/ShortYes / Yes LT Debt/Eq1.10 EPS Q/Q-27.25% Payout47.48% Rel Volume0.85 Prev Close39.07
Sales Surprise3.45% EPS Surprise16.85% Sales Q/Q10.54% EarningsJul 31 BMO Avg Volume3.60M Price39.86
SMA202.51% SMA50-3.07% SMA2000.31% Trades Volume3,063,074 Change2.02%
Date Action Analyst Rating Change Price Target Change
Jul-08-24Downgrade UBS Buy → Neutral
May-30-24Initiated Goldman Neutral $47
Mar-04-24Upgrade Guggenheim Neutral → Buy
Feb-13-24Upgrade Citigroup Neutral → Buy
Jan-23-24Initiated Morgan Stanley Equal-Weight $44
Jan-16-24Resumed UBS Buy
Jan-03-24Upgrade Jefferies Hold → Buy $48
Jul-14-23Initiated HSBC Securities Reduce
Mar-17-23Upgrade Deutsche Bank Hold → Buy
Feb-27-23Resumed Goldman Buy
Jul-24-24 10:01AM
Jul-22-24 06:24AM
Jul-17-24 08:00AM
06:30AM
Jul-16-24 09:40AM
06:15AM Loading…
Jul-12-24 06:15AM
Jul-11-24 08:00AM
07:00AM
Jul-09-24 01:30PM
12:33PM
Jul-08-24 11:42PM
01:30PM
12:34PM
Jul-04-24 12:00PM
10:01AM
12:49PM Loading…
Jul-03-24 12:49PM
11:49AM
10:09AM
08:19AM
06:23AM
05:21AM
04:43AM
02:40AM
Jul-01-24 10:24AM
Jun-27-24 10:05PM
03:28PM
03:13PM
11:08AM
10:07AM
09:40AM
08:40AM Loading…
08:40AM
07:53AM
03:16AM
Jun-26-24 10:12PM
05:05PM
12:54PM
12:22PM
Jun-24-24 01:02PM
Jun-20-24 10:00AM
Jun-16-24 08:00AM
08:00AM
Jun-14-24 06:45PM
07:15AM
Jun-12-24 09:03AM
Jun-11-24 09:40AM
06:00AM
05:05AM
Jun-07-24 06:57PM
11:36AM
11:35AM
Jun-06-24 05:23PM
09:03AM
Jun-04-24 07:15AM
Jun-03-24 05:08PM
03:44PM
01:42PM
01:19PM
01:17PM
12:18PM
11:53AM
11:46AM
11:30AM
10:52AM
10:13AM
08:10AM
07:05AM
Jun-02-24 10:56AM
May-31-24 05:01PM
12:18PM
12:07PM
11:31AM
May-25-24 11:10PM
May-24-24 03:45PM
08:04AM
May-23-24 09:50AM
May-21-24 05:07PM
02:48PM
01:56PM
11:43AM
10:31AM
07:50AM
06:07AM
03:11AM
May-20-24 04:27PM
May-17-24 09:06AM
03:07AM
May-16-24 06:15AM
May-15-24 07:02AM
May-14-24 08:21AM
07:08AM
May-13-24 05:23PM
May-10-24 04:53PM
May-09-24 06:00AM
May-08-24 03:15PM
09:40AM
May-07-24 10:15AM
01:00AM
May-06-24 02:12PM
10:47AM
May-05-24 08:44AM
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GSK plc10% OwnerDec 07 '23Buy5.003,300,00016,500,00013,983,761Jan 30 04:39 PM